
|Articles|May 3, 2004
NCCN recommends three agents for colorectal cancer
New recommendations have been issued by NCCN on treatment of colorectal cancer
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Emergence of CGRP-Targeted Therapies is Transforming Migraine Care | NCPA 2025
2
FDA Approves Tezepelumab for as Add-On Treatment for Chronic Rhinosinusitis With Nasal Polyps
3
FDA Approves Oral Semaglutide for Risk of MACE for Patients With Diabetes
4
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants
5